Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural effusions.

L B Reeder1

  • 1Cardiac and Thoracic Surgery, Henry Ford Hospital, 2799 West Grand Blvd., K-14, Detroit, MI 48202, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurogenic tumors of the mediastinum.

Seminars in thoracic and cardiovascular surgery·2001
Same author

Mortality after esophagectomy: risk factor analysis.

World journal of surgery·1997
Same author

Outcome after failed initial therapy for rupture of the esophagus or intrathoracic stomach.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·1997
Same author

Characterization of the effects of histamine in porcine tracheobronchial lymph vessels.

The American journal of physiology·1996
Same author

Results of myotomy and partial fundoplication after pneumatic dilation for achalasia.

The Annals of thoracic surgery·1996
Same author

Endothelin-1 synthesis and receptor-mediated activity in porcine lymph vessels.

The Journal of surgical research·1996
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Malignant pleural effusions cause significant distress in cancer patients. Talc pleurodesis via chest tube is an effective, cost-efficient palliative treatment for recurrent malignant pleural effusions, improving quality of life.

Area of Science:

  • Oncology
  • Pulmonology
  • Palliative Care

Background:

  • Malignant pleural effusions are a common complication in cancer patients, leading to significant morbidity and poor prognosis.
  • Treatment focuses on palliative care, emphasizing quality of life and balancing therapeutic risks and benefits.

Purpose of the Study:

  • To discuss the management of malignant pleural effusions, focusing on palliative options.
  • To highlight the importance of patient-centered decision-making regarding treatment choices.

Main Methods:

  • Review of current treatment strategies for malignant pleural effusions.
  • Discussion of the efficacy and limitations of various interventions, including thoracentesis and chest tube insertion.
  • Emphasis on chemical pleurodesis using talc as a primary sclerosant.

Related Experiment Videos

Main Results:

  • Recurrent malignant pleural effusions often necessitate interventions beyond simple thoracentesis.
  • Chemical pleurodesis, particularly with talc, is effective in achieving pleural symphysis and preventing recurrence.
  • Talc pleurodesis offers good efficacy, cost-effectiveness, and can be performed bedside with minimal discomfort.

Conclusions:

  • Talc pleurodesis is the preferred method for managing recurrent malignant pleural effusions due to its efficacy, safety, and cost-effectiveness.
  • Patient participation in decision-making is crucial, considering factors like prognosis and procedural tolerance.
  • Standardized endpoints and follow-up methods are needed to better compare treatment efficacies.